This week hosts Mark Masselli and Margaret Flinter speak with Dr. Ashish Jha, Associate Dean for Research Translation and Global Strategy at Harvard T.H. Chan School of Public Health. They discuss his recent report analyzing American health care costs compared to 10 other industrialized nations pointing to lack a of data and price transparency as drivers, suggesting that a combination of public policy and private innovations will lead to an “American solution” to the cost problem.
This week on Conversations on Health Care, hosts Mark Masselli and Margaret Flinter speak with Dr. David Hemenway, Director of the Harvard Injury Control Research Center at the Harvard T.H. Chan School of Public Health. He has spent decades researching America’s gun violence epidemic, its root causes, the casualties and public health and legal policies that would mitigate the problem.
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Michael Caligiuri, President of the American Association for Cancer Research representing 37 thousand cancer researchers worldwide. Dr. Caligiuri is also Director of the Ohio State Comprehensive Cancer Center and discusses breakthroughs in genomics, immunotherapy and prevention that are powerful weapons in the war on cancer.
This week, Hosts Mark Masselli and Margaret Flinter speak with Dr. Glenn Steele, President and CEO of Geisinger Health System in Pennsylvania, a physician-led, integrated health system serving 2.8 million patients across 44 counties. Dr. Steele discusses Geisinger’s integrated health services organization lauded for its innovative care delivery models and cost containment strategies that have yielded better outcomes and high-value care.
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Kyu Rhee, IBM’s Vice President of Integrated Health Services and medical adviser to Watson, IBM’s cognitive computing system which has been adapted for health care. Dr. Rhee discusses Watson’s ability to cognitively adapt to new information and as well as the new partnerships formed with Apple, Johnson and Johnson and others to scale up the aggregation and analysis of big health data in the clinical and research settings.
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Harvey Fineberg, President of the Institute of Medicine at the National Academy of Sciences. Dr. Fineberg discusses the research initiatives being undertaken by IOM that are designed to improve health care and public health through policy initiatives that support evidence-based outcomes.